![]() |
|
|
Vol. 284, Issue 3, 1174-1179, March 1998
Department of Pharmacology, Faculty of Medicine, Laval University,
and Quebec Heart Institute, Research Centre, Laval Hospital,
Sainte-Foy, Quebec, Canada
Modulation of intercellular coupling through gap junctions can
lead to a decrease in conduction velocity and conduction block. Previous studies have suggested that antiarrhythmic agents alter the
internal resistance (sum of cytoplasmic and gap junctions resistances)
of cardiac fibers. The objective of this study was to directly assess
the effect of antiarrhythmic agents on junctional resistance between
two isolated cells using the double whole-cell patch-clamp technique.
The experimental protocol consisted in holding the membrane potential
of each guinea pig ventricular myocyte of a coupled cell pair at 0 mV.
Then, a junctional voltage gradient was created by changing membrane
potential in only one cell. Voltage gradients were varied between
50
to +50 mV in steps of 20 mV. The extracellular medium was set to
minimize trans-sarcolemmal currents and the junctional current was
recorded in the cell maintained at 0 mV. Drugs tested were quinidine,
lidocaine, procainamide, flecainide, propranolol, sotalol, amiodarone
and verapamil. Drugs were superfused after a control period of 5 min.
during which junctional resistance was observed to be stable. None of
the antiarrhythmic agents tested in this study directly affected
junctional resistance, although procainamide slightly increased
junctional resistance 110 ± 8% after 10 min of exposure. In
conclusion, drugs tested in this study, chosen among all classes of
antiarrhythmic agents, did not affect junctional resistance of cardiac
myocyte cell pairs. However, long-term modulation or indirect effects
of antiarrhythmic agents on gap junctions under physiological
conditions cannot be excluded.
This article has been cited by other articles:
![]() |
P. Kojodjojo, P. Kanagaratnam, O. R. Segal, W. Hussain, and N. S. Peters The Effects of Carbenoxolone on Human Myocardial Conduction: A Tool to Investigate the Role of Gap Junctional Uncoupling in Human Arrhythmogenesis J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1242 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, V. V. Patel, and G. L. Radice Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis. Clin. Med. Res., March 1, 2006; 4(1): 42 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Jorgensen, S. C. Teilmann, Z. Henriksen, E. Meier, S. S. Hansen, J.-E. B. Jensen, O. H. Sorensen, and J. S. Petersen The Antiarrhythmic Peptide Analog Rotigaptide (ZP123) Stimulates Gap Junction Intercellular Communication in Human Osteoblasts and Prevents Decrease in Femoral Trabecular Bone Strength in Ovariectomized Rats Endocrinology, November 1, 2005; 146(11): 4745 - 4754. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R de Groot and R. Coronel Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis Cardiovasc Res, May 1, 2004; 62(2): 323 - 334. [Abstract] [Full Text] [PDF] |
||||